Empower Clinics In Advanced Discussions With Large US Pharmacies As Proposed Acquisition Includes Products In 4,000 Canadian Pharmacies

As if today's press release wasn't good enough Empower Clinics Announces Major Expansion with Proposed Acquisition of Medisure  Canada. Diabetes Tests and Devices Carried In 4,000 Pharmacies and  Generated $1.9m in 2020 Revenue, shareholders also received this injection of confidence from CEO Steve McAuley: "As I've stated to our shareholders on multiple occasions throughout 2021, Empower  is in the strongest position it has ever been and will continue to grow  every aspect of our business unabated and without interruption. In addition to this acquisition, in the last 30 days alone we have  announced expansions of our clinics, gone live on our KAI Saliva RT-PCR  test with Air Canada and are very advanced on tripling the size of the  KAI Medical Laboratory facility. We are hitting on all cylinders and  well on our way to becoming a major vertically integrated healthcare  company. I fully expect Empower to have continued strong business announcements in June and throughout 2021" If that was all,  it would be a great day ... and it was with $CBDT closing up 16.5% on  7.5M shares to $0.53 ... but then Steve shared some powerful information  about leveraging this acquisition with large US pharmacies. Who did he name? Watch this great interview with CEO Steve McAuley